Chemoinformaics analysis of Dihydrogalangal acetate
| Molecular Weight | 236.267 | nRot | 4 |
| Heavy Atom Molecular Weight | 220.139 | nRig | 2 |
| Exact Molecular Weight | 236.105 | nRing | 1 |
| Solubility: LogS | -5.402 | nHRing | 0 |
| Solubility: LogP | 5.815 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 35.5867 |
| nHD | 0 | BPOL | 21.2593 |
| QED | 0.275 |
| Synth | 2.185 |
| Natural Product Likeliness | 1.484 |
| NR-PPAR-gamma | 0.106 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.015 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.657 |
| MDCK | 0.0000201 |
| BBB | 0.925 |
| PPB | 0.968897 |
| VDSS | 2.017 |
| FU | 0.0221415 |
| CYP1A2-inh | 0.91 |
| CYP1A2-sub | 0.29 |
| CYP2c19-inh | 0.661 |
| CYP2c19-sub | 0.416 |
| CYP2c9-inh | 0.341 |
| CYP2c9-sub | 0.951 |
| CYP2d6-inh | 0.112 |
| CYP2d6-sub | 0.35 |
| CYP3a4-inh | 0.342 |
| CYP3a4-sub | 0.09 |
| CL | 2.535 |
| T12 | 0.261 |
| hERG | 0.051 |
| Ames | 0.205 |
| ROA | 0.255 |
| SkinSen | 0.976 |
| Carcinogencity | 0.469 |
| EI | 0.964 |
| Respiratory | 0.965 |
| NR-Aromatase | 0.036 |
| Antiviral | Yes |
| Prediction | 0.528966 |